US stocks fell on Friday as investors reacted to the threat of more possible tariffs from the Trump administration, while ...

European shares declined on Friday, driven by auto sector losses and trade war concerns. Porsche's profit warning and ...

Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III FRONTIER3 trial. The company plans to file for approval this year, hoping to ...

The S&P 500 ( ^GSPC) moved 0.5% lower, while the tech-heavy Nasdaq Composite ( ^IXIC) slid 0.8%. The Dow Jones Industrial ...

Inflation expectations jumped amid concerns about President Donald Trump's tariff threats. Americans now expect a rate of 4.3 ...

The S&P 500 ( ^GSPC) and the tech-heavy Nasdaq Composite ( ^IXIC) hovered just above the flatline. The Dow Jones Industrial ...

Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...

Good news for the sector came January 23 when global pharmaceutical giant AstraZeneca plc announced an eye-popping $820 ...

New York, New York-- (Newsfile Corp. - February 7, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Novo Nordisk (NYSE: NVO) and certain ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Trademark prosecution data reveals how the rival healthcare companies are ensuring exclusivity internationally for their ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...